Biogen shares jump on plans to move into late-stage trials of Alzheimer's drug
December 02, 2014 at 09:53 AM EST
Biogen Idec this morning reported promising news from an early-stage trial of its drug to treat Alzheimer's, a disease which threatens to weigh heavily on healthcare costs worldwide in coming years...
